Page last updated: 2024-11-05

vigabatrin and Huntington Disease

vigabatrin has been researched along with Huntington Disease in 3 studies

Huntington Disease: A familial disorder inherited as an autosomal dominant trait and characterized by the onset of progressive CHOREA and DEMENTIA in the fourth or fifth decade of life. Common initial manifestations include paranoia; poor impulse control; DEPRESSION; HALLUCINATIONS; and DELUSIONS. Eventually intellectual impairment; loss of fine motor control; ATHETOSIS; and diffuse chorea involving axial and limb musculature develops, leading to a vegetative state within 10-15 years of disease onset. The juvenile variant has a more fulminant course including SEIZURES; ATAXIA; dementia; and chorea. (From Adams et al., Principles of Neurology, 6th ed, pp1060-4)

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19903 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Gale, K1
Casu, M1
Scigliano, G1
Giovannini, P1
Girotti, F1
Grassi, MP1
Caraceni, T1
Schechter, PJ1
Hammond, EJ1
Wilder, BJ1

Reviews

2 reviews available for vigabatrin and Huntington Disease

ArticleYear
Dynamic utilization of GABA in substantia nigra: regulation by dopamine and GABA in the striatum, and its clinical and behavioral implications.
    Molecular and cellular biochemistry, 1981, Sep-25, Volume: 39

    Topics: 4-Aminobutyrate Transaminase; Afferent Pathways; Aminocaproates; Animals; Basal Ganglia; Behavior, A

1981
Gamma-vinyl GABA.
    General pharmacology, 1985, Volume: 16, Issue:5

    Topics: 4-Aminobutyrate Transaminase; Amino Acids; Aminocaproates; Animals; Behavior, Animal; beta-Alanine;

1985

Trials

1 trial available for vigabatrin and Huntington Disease

ArticleYear
Gamma-vinyl GABA treatment of Huntington's disease.
    Neurology, 1984, Volume: 34, Issue:1

    Topics: Aminocaproates; Double-Blind Method; Female; Humans; Huntington Disease; Male; Middle Aged; Vigabatr

1984